FMT Capsules for rCDI

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Clostridioides Difficile Infection Recurrence, FMT

In brief

Double blind RCT study of tretment of recurrent Clostridioides difficile infection by FMT capsules.

Key facts

Study ID

NCT07458984

Run by

Helsinki University Central Hospital

People needed

76

Starts

2026-04-25

Expected to finish

2030-12-31

Last updated by the study team

2026-04-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least twice recurrent CDI*
• Patient has had CDI-related diarrhea during infections (3 or more Bristol Stool Form Scale type 6-7 stools)
• Other causes of diarrhea have been excluded based on clinical data
• Age over 18 years
• Remission of symptoms during antibiotic course (metronidazole, vancomycin or fidaxomicin)
• No other antibiotic courses
• Able to sign the consent form or accept it electronically via Suomi.fi identification
• definition of recurrent CDI: CDI-compatible symptoms and a positive stool test Clostridioides difficile nucleic acid test within 12 weeks of the previous infection

You may not qualify if…

• Pregnancy
• Continuous need for antibiotic treatment
• Previous anaphylactic reactions to any food
• Gastroparesis
• Life-threatening fulminant CDI
• Life expectancy less than 1 year
• Inability to sign a consent form for the study

Where it is running

• Helsinki University Hospital — Helsinki, Uusimaa, Finland (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.